| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 18 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 18 |
| 2 | TACROLIMUS OINTMENT 0.1% | 18 |
| 3 | PREDNISONE | 17 |
| 4 | PREDNISOLONE | 15 |
| 5 | PREDNISOLONE ORAL | 15 |
| 6 | PREDNISOLONE ORAL SOLUTION | 15 |
| 7 | METRONIDAZOLE | 13 |
| 8 | METRONIDAZOLE TOPICAL | 13 |
| 9 | OMALIZUMAB | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 9 | 0.0258 |
| 1 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 2 | AIRBORNE | 1 | 0.0015 |
| 3 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 4 | MEBENDAZOLE | 1 | 0.0013 |
| 5 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| 6 | OLEZARSEN SODIUM | 1 | 0.0011 |
| 7 | ALBENDAZOLE | 2 | 0.0011 |
| 8 | EVEROLIMUS TABLETS | 11 | 0.0006 |
| 9 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 36 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 25 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 18 |
| 3 | Kinase Inhibitor [EPC] | 17 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 5 | Integrin Receptor Antagonist [EPC] | 13 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 13 |
| 7 | Anti-IgE [EPC] | 12 |
| 8 | Platinum-based Drug [EPC] | 12 |
| 9 | mTOR Inhibitor Immunosuppressant [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Non-Standardized House Dust Allergenic Extract [EPC] | 1 | 0.0013 |
| 2 | Standardized Animal Hair Allergenic Extract [EPC] | 1 | 0.0012 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Antiprotozoal [EPC] | 11 | 0.0010 |
| 5 | Anthelmintic [EPC] | 2 | 0.0007 |
| 6 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 7 | Antiparasitic [EPC] | 2 | 0.0004 |
| 8 | Pediculicide [EPC] | 2 | 0.0004 |
| 9 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |